Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Schulte

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Neuro-Oncology|February 27, 2016
Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferationAnnegret Kathagen-Buhmann, Alexander Schulte, Jonathan Weller, et al.
Journal of Neurochemistry|June 7, 2005
Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cellsAndreas Ludwig, Alexander Schulte, Cathrin Schnack, et al.
International Journal of Molecular Sciences|February 28, 2020
Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In VivoAlexander Schulte, Florian Ewald, Melanie Spyra, et al.
Neuro-Oncology|July 24, 2013
Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δAlexander Schulte, Katrin Liffers, Annegret Kathagen, et al.
Neuro-Oncology|December 29, 2014
Inhibition of intracerebral glioblastoma growth by targeting the insulin-like growth factor 1 receptor involves different context-dependent mechanismsMartin Zamykal, Tobias Martens, Jakob Matschke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2012
Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentrationAlexander Schulte, Hauke S Günther, Tobias Martens, et al.
The Journal of Investigative Dermatology|March 17, 2007
Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skinFelix Scholz, Alexander Schulte, Frederic Adamski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2015
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting GlioblastomaNadja Müller, Susanne Michen, Stefanie Tietze, et al.
Plos One|August 29, 2012
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapiesMichael Preukschas, Christian Hagel, Alexander Schulte, et al.
Oncotarget|September 30, 2015
EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cellsNina Struve, Matthias Riedel, Alexander Schulte, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Neuro-Oncology|February 27, 2016
Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferationAnnegret Kathagen-Buhmann, Alexander Schulte, Jonathan Weller, et al.
Journal of Neurochemistry|June 7, 2005
Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cellsAndreas Ludwig, Alexander Schulte, Cathrin Schnack, et al.
International Journal of Molecular Sciences|February 28, 2020
Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In VivoAlexander Schulte, Florian Ewald, Melanie Spyra, et al.
Neuro-Oncology|July 24, 2013
Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δAlexander Schulte, Katrin Liffers, Annegret Kathagen, et al.
Neuro-Oncology|December 29, 2014
Inhibition of intracerebral glioblastoma growth by targeting the insulin-like growth factor 1 receptor involves different context-dependent mechanismsMartin Zamykal, Tobias Martens, Jakob Matschke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2012
Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentrationAlexander Schulte, Hauke S Günther, Tobias Martens, et al.
The Journal of Investigative Dermatology|March 17, 2007
Constitutive expression and regulated release of the transmembrane chemokine CXCL16 in human and murine skinFelix Scholz, Alexander Schulte, Frederic Adamski, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 12, 2015
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting GlioblastomaNadja Müller, Susanne Michen, Stefanie Tietze, et al.
Plos One|August 29, 2012
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapiesMichael Preukschas, Christian Hagel, Alexander Schulte, et al.
Oncotarget|September 30, 2015
EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cellsNina Struve, Matthias Riedel, Alexander Schulte, et al.
Pageof 4